Biological and social values of metabolic syndrome in predicting cardiovascular disease

M Riva(Azienda Ospedaliera San Gerardo), G Cesana, Rita Facchetti(Laiko General Hospital of Athens), Carla Fornari, G. Mancia, Maurizio Ferrario(University of Insubria), M D’Orso, Giovanni Veronesi(University of Insubria), R. Sega
BOA (University of Milano-Bicocca)
January 1, 2009
Cited by 1

Related Papers

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population
|Circulation|2005|1k
Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial
|The Lancet|2018|793
Long-Term Risk of Mortality Associated With Selective and Combined Elevation in Office, Home, and Ambulatory Blood Pressure
|Hypertension|2006|693
Long-Term Prognostic Value of Blood Pressure Variability in the General Population
|Hypertension|2007|375